Methods for producing single pluripotent stem cells and differentiation thereof
The present invention relates to the field of pluripotent stem cell culture and methods facilitate pluripotent stem cell culture at industrial levels.
1. A method for differentiating pluripotent stem cells, comprising the steps of:
a) culturing the pluripotent stem cells as clusters in conditioned medium;
b) releasing the pluripotent stem cells as single cells by treatment with TrypLE™SELECT or TrypLE™EXPRESS in a concentration of from about 0.5 g/l to about 2.5 g/l for two minutes, wherein from 2.6 to 3.15×10 5 single cells are released from the pluripotent stem cell clusters, and wherein there is no gain of chromosome abnormalities after releasing the single cells from the clusters; and
c) differentiating the single pluripotent stem cells plated on a tissue culture substrate into definitive endoderm cells.
2. The method of claim 1 , wherein the pluripotent stem cells are released as single cells by treatment with TrypLE™SELECT.
3. The method of claim 1 , wherein the pluripotent stem cells are released as single cells by treatment with TrypLE™EXPRESS.
4. The method of claim 1 , wherein the pluripotent stem cells are released as single cells by treatment with TrypLE™SELECT or TrypLE™EXPRESS at a concentration of about 0.5 g/l.
5. The method of claim 1 , wherein the pluripotent stem cells are released as single cells by treatment with TrypLE™SELECT or TrypLE™EXPRESS at a concentration of about 2.5 g/l.
6. The method of claim 3 , wherein the pluripotent stem cells are released as single cells by treatment with TrypLE™EXPRESS at a concentration from about 1× to about 0.001×.
7. The method of claim 3 , wherein the pluripotent stem cells are released as single cells by treatment with TrypLE™EXPRESS at a concentration of 1×.
8. The method of claim 1 , wherein the tissue culture substrate is selected from the group consisting of MATRIGEL™, fibronectin, laminin, human serum and collagen.
9. The method of claim 8 , wherein the tissue culture substrate is MATRIGEL™.
10. The method of claim 9 , wherein the MATRIGEL™ is used at a dilution from about 1:30 to about 1:10.
11. The method of claim 10 , wherein the MATRIGEL™ is used at a dilution of 1:10.
12. The method of claim 1 , wherein the pluripotent stem cells are embryonic stem cells.
13. The method of claim 12 , wherein the embryonic stem cells are human.
14. The method of claim 1 , wherein the single pluripotent stem cells are differentiated into definitive endoderm cells by culturing the cells in a medium comprising activin A.
15. The method of claim 14 , wherein the definitive endoderm cells are further differentiated into one or more of pancreatic endoderm cells, pancreatic endocrine cells, pancreatic hormone-secreting cells or β-cells.
16. A method for differentiating pluripotent stem cells, comprising the steps of:
a) culturing the pluripotent stem cells as clusters in MEF conditioned medium;
b) releasing the pluripotent stem cells as single cells by treatment with a recombinant trypsin for at least two minutes, wherein from 2.6 to 3.15×10 5 single cells are released from the pluripotent stem cell clusters, and wherein there is no gain of chromosome abnormalities after releasing the single cells from the clusters; and
c) differentiating the single pluripotent stem cells plated on a tissue culture substrate or a MEF feeder layer into definitive endoderm cells.
17. The method of claim 1 , wherein the step of releasing comprises treatment with TrypLE™SELECT or TrypLE™EXPRESS followed by centrifugation.
18. The method of claim 16 , wherein the step of releasing comprises treatment with the recombinant trypsin followed by centrifugation.
19. The method of claim 1 , wherein the step of releasing results in no loss in pluripotency.
20. The method of claim 16 , wherein the step of releasing results in no loss in pluripotency.
21. The method of claim 1 , wherein the step of differentiating the single pluripotent stem cells comprises culturing the cells in a medium supplemented with a Gsk3b inhibitor.
22. The method of claim 16 , wherein the step of differentiating the single pluripotent stem cells comprises culturing the cells in a medium supplemented with a Gsk3b inhibitor.
23. The method of claim 1 , wherein the method further comprises passaging the single cells prior to differentiation.
24. The method of claim 16 , wherein the method further comprises passaging the single cells prior to differentiation.
25. The method of claim 16 , wherein the method comprises differentiating the single pluripotent stem cells plated on a MEF feeder layer into definitive endoderm cells.